Table 4List of participating stakeholders

CategorySubcategoryNo. of Stakeholders Who Prioritized the Final List of FRN topics
Patients and the publicNKF Patient & Family Council2
ProvidersClinicians – Nephrologist3
Clinical Chemist (Nominator)
Allied Health - Dietician
PayersPrivate Insurer (0 participated)*1
CMS (2 participated)**
Policy MakersNIDDK – Division of Kidney, Urologic & Hematologic Diseases1
Principal investigators/researchersClinical Researcher2
TOTAL9

Abbreviations: CMS = Center for Medicare and Medicaid Services; NIDDK = National Institute of Diabetes and Digestive and Kidney Disease; NKF = National Kidney Foundation

*

Invited but declined.

**

There were two stakeholders representing CMS but they jointly prioritized the final list of FRN topics.

Invited but declined.

There were two stakeholders representing CMS but they jointly prioritized the final list of FRN topics.

From: Results

Cover of Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs: Identification of Future Research Needs From Comparative Effectiveness Review No. 83 [Internet].
Future Research Needs Papers, No. 33.
Chung M, Chan JA, Moorthy D, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.